STOCK TITAN

[SCHEDULE 13G/A] Verastem, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Verastem, Inc. received a Schedule 13G/A amendment from Barclays PLC reporting that Barclays holds 0.00 shares of Verastem common stock and asserts no voting or dispositive power. The filing classifies Barclays as a HC reporting person and states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control.

The filing lists Barclays subsidiaries (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) in connection with the parent holding company disclosure; overall the document indicates no material ownership position or control intent by Barclays in Verastem.

Verastem, Inc. ha ricevuto un emendamento al Schedule 13G/A da Barclays PLC, che dichiara che Barclays detiene 0,00 azioni del capitale ordinario di Verastem e non esercita né potere di voto né potere di disposizione. Il deposito classifica Barclays come persona segnalante HC e precisa che le partecipazioni sono nell'ordinario svolgimento dell'attività e non hanno lo scopo di modificare o influenzare il controllo.

Il documento elenca le controllate di Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) ai fini della disclosure sulla società madre; nel complesso indica l'assenza di una posizione di proprietà rilevante o di un intento di controllo da parte di Barclays in Verastem.

Verastem, Inc. recibió una enmienda al Schedule 13G/A por parte de Barclays PLC, que informa que Barclays posee 0,00 acciones de las acciones ordinarias de Verastem y afirma no tener poder de voto ni poder de disposición. La presentación clasifica a Barclays como persona informante HC y señala que las participaciones están en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control.

El documento enumera las subsidiarias de Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) en relación con la divulgación de la sociedad matriz; en conjunto, indica que Barclays no tiene una posición de propiedad material ni intención de control sobre Verastem.

Verastem, Inc.는 Barclays PLC로부터 Schedule 13G/A 수정보고서를 받았으며, Barclays가 Verastem 보통주 0.00주를 보유하고 있고 의결권이나 처분권이 없다고 보고했습니다. 해당 신고서는 Barclays를 보고자 HC로 분류하고, 보유는 영업의 통상적인 범위 내에 있으며 지배권을 변경하거나 영향을 미치려는 목적이 아니라고 명시합니다.

신고서에는 모회사 보유 공시와 관련해 Barclays의 자회사들(Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd)이 기재되어 있으며, 전반적으로 문서는 Verastem에 대한 Barclays의 실질적 소유지분이나 지배 의도가 없음을 나타냅니다.

Verastem, Inc. a reçu un amendement au Schedule 13G/A de Barclays PLC, qui déclare que Barclays détient 0,00 actions des actions ordinaires de Verastem et n'exerce aucun pouvoir de vote ni pouvoir de disposition. Le dépôt classe Barclays comme personne déclarante HC et indique que les participations sont détenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle.

Le dépôt énumère les filiales de Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) dans le cadre de la divulgation relative à la société mère ; dans l'ensemble, le document indique que Barclays n'a pas de position de propriété significative ni d'intention de contrôle sur Verastem.

Verastem, Inc. erhielt eine Änderung zum Schedule 13G/A von Barclays PLC, die angibt, dass Barclays 0,00 Aktien der Stammaktien von Verastem hält und keine Stimm- oder Verfügungsgewalt ausübt. Die Einreichung stuft Barclays als meldende Person HC ein und erklärt, dass die Beteiligungen im normalen Geschäftsverlauf gehalten werden und nicht dazu dienen, die Kontrolle zu ändern oder zu beeinflussen.

In der Einreichung werden Barclays-Tochtergesellschaften (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) im Zusammenhang mit der Offenlegung der Muttergesellschaft aufgeführt; insgesamt deutet das Dokument darauf hin, dass Barclays keine wesentliche Eigentumsposition oder Kontrollabsicht an Verastem besitzt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine disclosure; Barclays reports no beneficial ownership or voting power in VSTM.

The Schedule 13G/A shows 0.00 shares beneficially owned by Barclays PLC and zero sole or shared voting and dispositive power. This is a routine compliance filing confirming Barclays does not hold a reportable economic stake in Verastem and is not pursuing control. For investors, the filing does not change the ownership landscape or imply strategic moves by a major holder.

TL;DR: No governance impact; filing affirms ordinary-course holdings and no intent to influence control.

Barclays explicitly certifies the securities were acquired and are held in the ordinary course of business and not to influence control. The parent/ subsidiary disclosure names relevant Barclays entities but does not attach any material ownership. From a governance perspective, this filing provides transparency but signals no change in board or control dynamics at Verastem.

Verastem, Inc. ha ricevuto un emendamento al Schedule 13G/A da Barclays PLC, che dichiara che Barclays detiene 0,00 azioni del capitale ordinario di Verastem e non esercita né potere di voto né potere di disposizione. Il deposito classifica Barclays come persona segnalante HC e precisa che le partecipazioni sono nell'ordinario svolgimento dell'attività e non hanno lo scopo di modificare o influenzare il controllo.

Il documento elenca le controllate di Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) ai fini della disclosure sulla società madre; nel complesso indica l'assenza di una posizione di proprietà rilevante o di un intento di controllo da parte di Barclays in Verastem.

Verastem, Inc. recibió una enmienda al Schedule 13G/A por parte de Barclays PLC, que informa que Barclays posee 0,00 acciones de las acciones ordinarias de Verastem y afirma no tener poder de voto ni poder de disposición. La presentación clasifica a Barclays como persona informante HC y señala que las participaciones están en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control.

El documento enumera las subsidiarias de Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) en relación con la divulgación de la sociedad matriz; en conjunto, indica que Barclays no tiene una posición de propiedad material ni intención de control sobre Verastem.

Verastem, Inc.는 Barclays PLC로부터 Schedule 13G/A 수정보고서를 받았으며, Barclays가 Verastem 보통주 0.00주를 보유하고 있고 의결권이나 처분권이 없다고 보고했습니다. 해당 신고서는 Barclays를 보고자 HC로 분류하고, 보유는 영업의 통상적인 범위 내에 있으며 지배권을 변경하거나 영향을 미치려는 목적이 아니라고 명시합니다.

신고서에는 모회사 보유 공시와 관련해 Barclays의 자회사들(Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd)이 기재되어 있으며, 전반적으로 문서는 Verastem에 대한 Barclays의 실질적 소유지분이나 지배 의도가 없음을 나타냅니다.

Verastem, Inc. a reçu un amendement au Schedule 13G/A de Barclays PLC, qui déclare que Barclays détient 0,00 actions des actions ordinaires de Verastem et n'exerce aucun pouvoir de vote ni pouvoir de disposition. Le dépôt classe Barclays comme personne déclarante HC et indique que les participations sont détenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle.

Le dépôt énumère les filiales de Barclays (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) dans le cadre de la divulgation relative à la société mère ; dans l'ensemble, le document indique que Barclays n'a pas de position de propriété significative ni d'intention de contrôle sur Verastem.

Verastem, Inc. erhielt eine Änderung zum Schedule 13G/A von Barclays PLC, die angibt, dass Barclays 0,00 Aktien der Stammaktien von Verastem hält und keine Stimm- oder Verfügungsgewalt ausübt. Die Einreichung stuft Barclays als meldende Person HC ein und erklärt, dass die Beteiligungen im normalen Geschäftsverlauf gehalten werden und nicht dazu dienen, die Kontrolle zu ändern oder zu beeinflussen.

In der Einreichung werden Barclays-Tochtergesellschaften (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) im Zusammenhang mit der Offenlegung der Muttergesellschaft aufgeführt; insgesamt deutet das Dokument darauf hin, dass Barclays keine wesentliche Eigentumsposition oder Kontrollabsicht an Verastem besitzt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Barclays PLC
Signature:Ramya Rao
Name/Title:Director
Date:08/12/2025

FAQ

What does the Schedule 13G/A filed for VSTM disclose?

The filing states Barclays PLC beneficially owns 0.00 shares (0%) of Verastem common stock and reports no voting or dispositive power.

Does Barclays intend to influence control of Verastem (VSTM)?

No; the filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control.

Which Barclays entities are identified in the filing for VSTM?

The filing lists Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd in the parent/subsidiary disclosure.

How is Barclays classified in this Schedule 13G/A for VSTM?

Barclays PLC is classified as a reporting person type HC (parent holding company) in the filing.

Does the Schedule 13G/A indicate a material ownership stake in VSTM?

No; the filing states ownership of 0.00 shares, which represents 0% of the class and is below reportable thresholds.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

451.13M
56.68M
0.93%
92.95%
32.95%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM